Literature DB >> 3485946

Characterization of inflammatory mediator release from purified human lung mast cells.

R P Schleimer, D W MacGlashan, S P Peters, R N Pinckard, N F Adkinson, L M Lichtenstein.   

Abstract

The release of inflammatory mediators (histamine, PGD2, TxB2, and LTC4) from purified human lung mast cells was characterized by kinetic and anti-IgE dose-response parameters. The relative rate of mediator release was histamine greater than PGD2 = TxB2 greater than LTC4, with one half maximal release occurring at approximately 2, 5, and 10 min, respectively. In 2 experiments, stimulation with anti-IgE caused significant quantities of platelet-activating factor (PAF) to appear rapidly (2 min) in the cell pellet; cell-associated PAF declined to low levels by 45 min. The optimal concentration of anti-IgE for the release of the arachidonate cyclooxygenase metabolites PGD2 and TxB2 (0.3 microgram/ml) was 10- to 30-fold less than that required for the release of histamine and LTC4 (3 to 10 micrograms/ml), suggesting that these release processes may have differential IgE Fc receptor cross-linking requirements. At optimal histamine release, the magnitude of the release of each arachidonate metabolite was found to correspond to the magnitude of histamine release, however, suggesting that the 2 processes are linked either in series or in parallel.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485946     DOI: 10.1164/arrd.1986.133.4.614

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  23 in total

1.  Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds.

Authors:  C M Hogaboam; D Donigi-Gale; T S Shoupe; E Y Bissonnette; A D Befus; J L Wallace
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  Effect of nedocromil sodium on allergen-, PAF-, histamine- and bradykinin-induced airways vasodilatation and pulmonary obstruction in the pig.

Authors:  K Alving; R Matran; J M Lundberg
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

Review 3.  Pros and Cons of Clinical Basophil Testing (BAT).

Authors:  Hans Jürgen Hoffmann; Edward F Knol; Martha Ferrer; Lina Mayorga; Vito Sabato; Alexandra F Santos; Bernadette Eberlein; Anna Nopp; Donald MacGlashan
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

4.  Purification of rat cutaneous mast cells with Percoll density centrifugation.

Authors:  H Hachisuka; M Kusuhara; M Higuchi; K Okubo; Y Sasai
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

Review 5.  PAF antagonists. Their potential therapeutic role in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

6.  The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways.

Authors:  D T Schmidt; N Watson; G Dent; E Rühlmann; D Branscheid; H Magnussen; K F Rabe
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

7.  Pharmacological characterization of mediators and vagal influence in the acute allergic bronchoconstriction in guinea pigs.

Authors:  M H Vargas; L M Montaño; B Vanda; P Segura; M Selman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

8.  Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell.

Authors:  M Triggiani; A N Fonteh; F H Chilton
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

9.  Mast cell activation enhances airway responsiveness to methacholine in the mouse.

Authors:  T R Martin; T Takeishi; H R Katz; K F Austen; J M Drazen; S J Galli
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Contribution of thromboxane A2 to the antigen-induced immediate asthmatic response mediated by IgG1 antibody by augmentation of bronchial responsiveness in guinea-pigs.

Authors:  A Arimura; F Asanuma; A Kurosawa; M Harada
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.